What Alithia Life Sciences does

Alithia Life Sciences is a privately-held, Australian-owned full-service Contract Research Organisation headquartered in Melbourne and operating across Australia, New Zealand, and selected global markets via a partner network. The company provides end-to-end clinical trial services to biotech, pharmaceutical, MedTech, digital health, and investor clients, structured around three integrated offerings: Strategy & Advisory (regulatory strategy, KOL engagement, indicative cost/timeline estimates), Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight), and Local Directorship (enabling international sponsors to conduct trials in Australia with local governance). Its core technology stack is operational rather than productized — clinical research operations and project management for end-to-end trial delivery — and it does not disclose proprietary software products.

The company monetizes through professional services contracts, with pricing quote-based and customized per project scope, therapeutic area, phase, and complexity. Its go-to-market is enterprise field sales, with the Founder/Director and CCO personally engaging clients, supplemented by industry events (BIO 2026, RESI San Diego 2026, ARCS Australia), webinars, LinkedIn presence, and a 20+ partner referral network spanning AusBiotech, ARCS, BioMelbourne Network, CCRM Australia, and global CROs. Key customer testimonials include Murdoch Children's Research Institute, Avecho Biotechnology, and PharmAust. Alithia's structural differentiator is leveraging Australia's regulatory environment — no IND requirement, GMP exemption for FIH studies, 2-3 month start-up timelines, up to 43.5% R&D cash tax incentive, and FDA/EMA-accepted data — packaged through its Local Directorship offering. The firm is founder-led by A/Prof Tina Soulis, supported by a CCO with IQVIA/Parexel/Medtronic background and a Director of Clinical Operations with 28 years of industry experience.

Name

Alithia Life Sciences

Legal name

Alithia Life Sciences

Website

https://alithialifesciences.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Alithia Life Sciences is a privately-held, Australian-owned boutique CRO headquartered in Melbourne that provides end-to-end clinical trial services — strategy, operational delivery, and local directorship — to biotech, pharma, MedTech, digital health, and investor clients across Australia, New Zealand, and global markets.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

Keywords

• Clinical trial services
• Contract research organization
• Biotech clinical development
• Regulatory strategy services
• Clinical operations management

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. CRO Services - Clinical Trial Management: Full-service Contract Research Organization providing clinical development program support, trial design, site strategy, project management, monitoring, site management, and vendor oversight. Revenue generated through service contracts for biotech, pharma, MedTech and digital health clients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Alithia Life Sciences is a proudly Australian-owned, full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services for biotech, pharma, MedTech, digital health sponsors, and investors. The company provides three integrated offerings: Strategy & Advisory (regulatory and clinical development strategy, KOL engagement, cost and timeline scenarios, Clinical Trial Liaison services); Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight); and Local Directorship (regulatory governance for international sponsors running trials in Australia/NZ).

Product overview

Alithia Life Sciences is an Australian-owned full-service Contract Research Organisation (CRO) offering a unified service portfolio rather than discrete software products. The company provides end-to-end clinical development services structured around three core integrated offerings: Strategy & Advisory (providing indicative estimates, timelines, cost scenarios, regulatory strategy, KOL engagement, and Clinical Trial Liaison services); Clinical & Operational Excellence (covering clinical development program optimization, trial design and site strategy, project management, operational delivery including monitoring and site management services, and vendor oversight); and Local Directorship (enabling international sponsors to conduct clinical trials in Australia with local regulatory compliance and governance). Services span multiple therapeutic areas (FIH and Healthy Volunteer studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, Vaccines) and support various investigational products including Drugs, Devices, Cell and Gene therapies, and Combination therapy trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategy & Advisory Strategy and Advisory services that turn clinical development complexity into clear direction through indicative cost and timeline estimates for planning, investor, and board discussions, regulatory and clinical development strategy, Key Opinion Leader (KOL) engagement, and Clinical Trial Liaison services acting as the client's local support person. Designed for biotech, pharma, MedTech, digital health sponsors, and investors needing strategic clarity before and during trial execution.
• Clinical & Operational Excellence Clinical and operational delivery service covering clinical development program optimization, trial design, site strategy, project management, monitoring and site management services, and vendor oversight with operational scale-up. Designed for biotech, pharma, MedTech, and digital health sponsors executing trials across therapeutic areas including FIH studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, and Vaccines.
• Local Directorship Local Directorship and governance service enabling international biotech, pharma, and MedTech sponsors to conduct clinical trials in Australia while meeting regulatory requirements. Provides clear governance, experienced local oversight, and Australian in-country representation for sponsors lacking a domestic presence.

Quantifiable outcome

• Rapid start-up: 2-3 months average from protocol to first patient
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

20 partnerships are on record, tiered minor.

• PureCDMminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section. PureCDM appears to be a clinical development management partner.
• Ichor Life SciencesminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
• Facet Life SciencesminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
• CCRM AustraliaminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section. CCRM focuses on cell and gene therapy.
• AusBiotechminorStrategic or Co-development PartnerPeak biotechnology industry body in Australia. Alithia maintains affiliation for industry networking and advocacy.
• ARCS AustraliaminorStrategic or Co-development PartnerAssociation for Clinical Research Site organizations. Alithia affiliated for industry standards and networking.
• BioMelbourne NetworkminorStrategic or Co-development PartnerMelbourne-based life sciences industry network. Alithia participates in events and collaborations.
• A Fortiori DevelopmentminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
• Movement Disorders Society of Australia and New Zealand Clinical Trials NetworkminorStrategic or Co-development PartnerClinical trials network focused on movement disorders research.
• FightMNDminorStrategic or Co-development PartnerFoundation fighting Motor Neurone Disease. Alithia affiliated for research collaboration.
• CeruleaminorStrategic or Co-development PartnerClinical trials organization partner listed in affiliations.
• NSW BiominorStrategic or Co-development PartnerNew South Wales biotechnology industry organization.
• Resolutum GlobalminorChannel Partner/ Reseller/ DistributorGlobal CRO partner for international trial expansion.
• ScendeaminorStrategic or Co-development PartnerEnvironmental and sustainability consulting partner.
• Central Pharmacy LogisticsminorStrategic or Co-development PartnerPharmaceutical logistics and distribution partner.
• University of Sunshine CoastminorStrategic or Co-development PartnerAcademic research institution partner for clinical trials.
• Nieman-PickCminorStrategic or Co-development PartnerClinical research network focused on Niemann-Pick disease.
• SmartCRCminorStrategic or Co-development PartnerClinical research coordination partner.
• EBPRGminorStrategic or Co-development PartnerEvidence-based practice research group partner.
• MaH-CTSminorStrategic or Co-development PartnerClinical trials support organization.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Avance Clinical: Largest Australian-owned boutique CRO, also marketed around Australia's regulatory and tax advantages for biotech sponsors. Direct head-to-head competitor for the same international biotech and Phase I/II inbound study work Alithia targets.
• CMAX Clinical Research: Adelaide-based Australian CRO specializing in early-phase clinical trials, including FIH and healthy-volunteer studies. Comparable boutique-scale CRO leveraging Australia's regulatory environment for biotech sponsors.
• Nucleus Network: Australian early-phase clinical trial and FIH specialist with clinical pharmacology units. Overlaps directly with Alithia's stated FIH, healthy-volunteer, and Phase I capabilities.

Broad incumbents

• ICON plc: Global CRO offering Phase I-IV clinical development services. Comparable broad-service incumbent that wins large multi-region programs Alithia can only access via partner hand-offs.
• Syneos Health: Global biopharmaceutical solutions organization with clinical and commercial services. Competes for biotech and pharma outsourcing dollars across the same functional areas Alithia serves.
• IQVIA: Largest global CRO/commercial life sciences services provider. Alithia's CCO previously worked at IQVIA; competes for enterprise pharma contracts that Alithia aspires to capture as it scales.
• Parexel: Top-tier global full-service CRO. Alithia's CCO previously held a role at Parexel; represents the global full-service delivery standard Alithia is positioning against at the boutique level.
• Charles River Laboratories: Global CRO and preclinical/research services provider. Larger-scale incumbent offering end-to-end development services that overlap with Alithia's biotech and pharma support offerings.

Emerging players

• Linical: Mid-sized global CRO with Asia-Pacific presence targeting similar biotech and specialty pharma sponsors. Comparable size tier to Alithia's aspiration scale with broader geographic footprint.

Regional players

• Novotech: Asia-Pacific focused mid-to-large CRO headquartered in Australia. Serves similar biotech sponsor base across the region but with substantially greater scale, full-service Phase I-IV delivery, and broader geographic reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alithia-life-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alithia Life Sciences